Tema Cardiovascular and M... (HRTS)
NASDAQ: HRTS
· Real-Time Price · USD
30.34
-0.41 (-1.33%)
At close: Sep 10, 2025, 2:04 PM
-1.33% (1D)
| Bid | 21.85 |
| Market Cap | 49.11M |
| AUM | 53.06M |
| NAV | 30.67 |
| EPS (ttm) | 1.27 |
| PE Ratio (ttm) | 23.83 |
| Shares Out | 1.62M |
| Inception Date | Nov 19, 2023 |
| Ask | 39.01 |
| Volume | 80,226 |
| Open | 30.77 |
| Previous Close | 30.75 |
| Day's Range | 30.27 - 30.77 |
| 52-Week Range | 25.32 - 35.53 |
| Holdings | 45 |
| Expense Ratio | 0.75% |
About HRTS
The actively managed Tema Heart & Health ETF seeks to provide long-term growth of capital by investing in GLP-1 and weight loss companies leading the fight against obesity and cardiometabolic diseases.
Asset Class Equity
Ticker Symbol HRTS
Inception Date Nov 19, 2023
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 41.18% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 7.71% |
| Unitedhealth Group I... | UNH | 4.59% |
| Abbott Laboratories | ABT | 4.53% |
| Roche Holding Ag | RHHBY | 4.33% |
| Boston Scientific Co... | BSX | 3.77% |
| Thermo Fisher Scient... | TMO | 3.46% |
| Abbvie Inc. | ABBV | 3.46% |
| Gilead Sciences, Inc... | GILD | 3.30% |
| Bridgebio Pharma, In... | BBIO | 3.09% |
| Crinetics Pharmaceut... | CRNX | 2.94% |
Dividends Dividend Yield 1.46%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 11, 2024 | $0.4693 | Dec 12, 2024 |
